Anderson MM, Lauring AS, Burns CC, Overbaugh J. (2000). Identification of a cellular
cofactor required for infection by feline leukemia virus. Science 287(5459):1828-30.
Barbacid M, Stephenson JR, Aaronson SA. (1977). Evolutionary relationships between gag
gene-coded proteins of murine and primate endogenous type C RNA viruses. Cell
10(4):641-8.
Besmer P (1983). Acute transforming feline retroviruses. In Vogt P, Koprowski H (eds):
Contemp Top Microbiol immunol 107:1.
Boretti, FS, P Ossent, K Bauer-Pham, B Weibel, T Meili, V Cattori, C Wolfensberger, M
Reinacher, H Lutz, and R Hofmann-Lehmann. (2004). Recurrence of feline leukemia
virus (FeLV) and development of fatal lymphoma concurrent with feline
immunodeficiency virus (FIV) induced immune suppression. Presented at the 7th
International Feline Retrovirus Research Symposium, Pisa, Italy.
Brunner C, Kanellos T, Meli ML, Sutton DJ, Gisler R, Gomes-Keller MA, Hofmann-
Lehmann R, Lutz H. (2006). Antibody induction after combined application of an
adjuvanted recombinant FeLV vaccine and a multivalent modified live virus vaccine
with a chlamydial component. Vaccine 24(11):1838-46.
Coffin JM. (1979). Structure, replication, and recombination of retrovirus genomes: some
unifying hypotheses. J Gen Virol 42(1):1-26.
Cotter SM. (1979). Anaemia associated with feline leukemia virus infection. J Am Vet Med
Assoc 175(11):1191-4.
de Mari K, Maynard L, Sanquer A, Lebreux B, Eun HM. (2004). Therapeutic effects of
recombinant feline interferon-omega on feline leukemia virus (FeLV)-infected and
FeLV/feline immunodeficiency virus (FIV)-coinfected symptomatic cats. J Vet Intern
Med 18(4):477-82.
Donner L, Fedele LA, Garon CF, Anderson SJ, Sherr CJ (1982). McDonough Feline sarcoma
virus: characterization of the molecularly cloned provirus and its feline oncogene (vfms).
J.Virol. 41, 489-500
Dow SW & Hoover EA (1992). Neurologic disease associated with feline retroviral infection.
P1010. In Kirk RW, Bonagura JD (Eds): Current Veterinary Therapy Vol XI, WB
Saunders, Philadelphia,
Ettinger, SN, (2003). Principles of treatment for feline lymphoma. Clin Tech Small Anim
Pract 18, 98-102
Floyd K, Suter PF, Lutz H. (1983). Granules of blood eosinophils are stained directly by antiimmunoglobulin
fluorescein isothiocyanate conjugates. Am J Vet Res 44(11):2060-3.
Flynn JN, Dunham SP, Watson V, Jarrett O. (2002). Longitudinal analysis of feline leukemia
virus-specific cytotoxic T lymphocytes: correlation with recovery from infection. J
Virol 76(5):2306-15.
Franchini M. (1990). Die Tollwutimpfung von mit felinem Leukämivirus infizierten Katzen,
Vet.Diss. Zürich Univ.
Francis DP, Cotter SM, Hardy WD, Jr., Essex M. (1979a). Comparison of virus-positive and
virus-negative cases of feline leukemia and lymphoma. Cancer Research 39(10):3866-
70.
Francis DP, Essex M, Gayzagian D. (1979b). Feline leukemia virus: survival under home and
laboratory conditions. J Clin Microbiol.;9(1):154-6.
Fulton R, Gasper PW, Ogilvie GK, Boone TC, Dornsife RE. (1991). Effect of recombinant
human granulocyte colony-stimulating factor on hematopoiesis in normal cats. Exp
Hematol 19(8):759-67.
Gomes-Keller MA, Gonczi E, Tandon R, Riondato F, Hofmann-Lehmann R, Meli ML, Lutz
H. (2006a). Detection of feline leukemia virus RNA in saliva from naturally infected
cats and correlation of PCR results with those of current diagnostic methods. J Clin
Microbiol 44(3):916-22.
Gomes-Keller MA, Tandon R, Gonczi E, Meli ML, Hofmann-Lehmann R, Lutz H. (2006b).
Shedding of feline leukemia virus RNA in saliva is a consistent feature in viraemic
cats. Vet Microbiol 112(1):11-21.
Grant CK, Essex M, Gardner MB, Hardy WD, Jr. (1980). Natural feline leukemia virus
infection and the immune response of cats of different ages. Cancer Research
40(3):823-829.
Haffer KN, Sharpee RL, Beckenhauer W, Koertje WD, Fanton RW (1987). Is the feline
leukaemia virus responsible for neurologic abnormalities in cats? Vet Med 82(8):802-
805.
Hardy WD, Jr., Geering G, Old LJ, de Harven E, Brodey RS, McDonough SK. (1970).
Serological studies of the feline leukemia virus. Bibl Haematol(36):343-54.
Hardy WD, Jr., Hirshaut Y, Hess P. (1973). Detection of the feline leukemia virus and other
mammalian oncornaviruses by immunofluorescence. Bibl Haematol 39:778-99.
Hardy WD, Jr., Hess PW, MacEwen EG, McClelland AJ, Zuckerman EE, Essex M, Cotter
SM, Jarrett O. (1976). Biology of feline leukemia virus in the natural environment.
Cancer Res 36(2 pt 2):582-8.
Hardy WD Jr: (1981). The feline sarcoma viruses. J Am Anim Hosp Assoc 17:981
Hartmann K, Block A, Ferk G, Vollmar A, Goldberg M, Lutz H. (1998). Treatment of feline
leukemia virus-infected cats with paramunity inducer. Vet Immunol Immunopathol
65:267-75.
Hartmann K, Werner RM, Egberink H, Jarrett O. (2001). Comparison of six in-house tests for
the rapid diagnosis of feline immunodeficiency and feline leukaemia virus infections.
Vet Rec 149(11):317-20.
Hartmann K. (2005). FeLV treatment strategies and prognosis. Suppl Compend Contin Educ
Pract Vet ;27:14-26
Hartmann K. (2006). Antiviral and immunodulatory chemotherapy. In: Greene CE (Ed).
Infectious Diseases of the Dog and Cat. 3rd edition. Elsevier Saunders, St. Louis,
USA,:10-25.
Hartmann K, Griessmayr P, Schulz B, Greene CE, Vidyashankar AN, Jarrett O, Egberink HF
(2007). Quality of different in-clinic test systems for feline immunodeficiency virus
and feline leukaemia virus infection. J Feline Med Surg;9(6):439-45]
Hawks DM, Legendre AM, Rohrbach BW. (1991). Comparison of four test kits for feline
leukemia virus antigen. Journal of the American Veterinary Medical Association
199(10):1373-7.
Hofmann-Lehmann R, Holznagel E, Aubert A, Ossent P, Reinacher M, Lutz H. (1995).
Recombinant FeLV vaccine: long-term protection and effect on course and outcome
of FIV infection. Veterinary Immunology & Immunopathology 46(1-2):127-37.
Hofmann-Lehmann R, Holznagel E, Ossent P, Lutz H. (1997). Parameters of disease
progression in long-term experimental feline retrovirus (feline immunodeficiency
virus and feline leukemia virus) infections: hematology, clinical chemistry, and
lymphocyte subsets. Clin Diagn Lab Immunol 4(1):33-42.
Hofmann-Lehmann R, Huder JB, Gruber S, Boretti F, Sigrist B, Lutz H. (2001). Feline
leukaemia provirus load during the course of experimental infection and in naturally
infected cats. J Gen Virol 82(Pt 7):1589-96.
Hofmann-Lehmann R, Tandon R, Boretti FS, Meli ML, Willi B, Cattori V, Gomes-Keller
MA, Ossent P, Golder MC, Flynn JN and others. (2006b). Reassessment of felineleukaemia virus (FeLV) vaccines with novel sensitive molecular assays. Vaccine
24(8):1087-94.
Hofmann-Lehmann R, Cattori V, Tandon R, Boretti FS, Meli ML, Riond B, Pepin AC, Willi
B, Ossent P, Lutz H. (2007). Vaccination against the feline leukaemia virus: Outcome
and response categories and long-term follow-up. Vaccine 25(30):5531-5539.
Hoover EA, Olsen RG, Hardy WD Jr, Schaller JP, Mathes LE (1976). Feline leukemia virus
infection: age-related variation in response of cats to experimental infection. J Natl
Cancer Inst. 57(2):365-9.
Hoover EA, Schaller JP, Mathes LE, Olsen RG. (1977). Passive immunity to feline leukemia:
evaluation of immunity from dams naturally infected and experimentally vaccinated.
Infect Immun 16(1):54-9.
Hosie MJ, Robertson C, Jarrett O. (1989). Prevalence of feline leukaemia virus and antibodies
to feline immunodeficiency virus in cats in the United Kingdom. Vet Rec 125(11):293-
7.
Jackson ML, Haines DM, Meric SM, Misra V. (1993). Feline leukemia virus detection by
immunohistochemistry and polymerase chain reaction in formalin-fixed paraffinembedded
tumor tissue from cats with lymphosarcoma. Can J Vet Res;57:269-276
Jackson ML, Haines DM, Taylor SM, Misra V. (1996). Feline leukemia virus detection by
ELISA and PCR in peripheral blood from 68 cats with high, moderate, or low
suspicion of having FeLV-related disease. J Vet Diagn Invest 8(1):25-30.
Jarrett O. (1980). Feline leukaemia virus diagnosis. Vet Rec 106(24):513.
Jarrett O, Golder MC, Weijer K. (1982). A comparison of three methods of feline leukaemia
virus diagnosis. Veterinary Record 110(14):325-8.
Jarrett WF, Crawford EM, Martin WB, Davie F. (1964). A Virus-Like Particle Associated
with Leukemia (Lymphosarcoma). Nature 202:567-9.
Jarrett W, Mackey L, Jarrett O, Laird H, Hood C. (1974). Antibody response and virus
survival in cats vaccinated against feline leukaemia. Nature 248(445):230-2.
Jarrett W, Jarrett O, Mackey L, Laird H, Hood C, Hay D (1975). Vaccination against feline
leukaemia virus using a cell membrane antigen system. Int J Cancer 16(1):134-41.
Kensil CR, Barrett C, Kushner N, Beltz G, Storey J, Patel U, Recchia J, Aubert A, Marciani
D. (1991). Development of a genetically engineered vaccine against feline leukemia
virus infection. Journal of the American Veterinary Medical Association
199(10):1423-7.
Kociba GJ (1986). Hematologic consequences of feline leukaemia virus infection p448. In
Kirk RW (Ed): Current Veterinary Therapy. Vol XIII. WB Saunders, Philadelphia,
Knowles JO, Gaskell RM, Gaskell CJ, Harvey CE, Lutz H. (1989). Prevalence of feline
calicivirus, feline leukaemia virus and antiboidies to FIV in cats with chronic
stomatitis. Vet Rec 124(13):336-338.
Lehmann R, Franchini M, Aubert A, Wolfensberger C, Cronier J, Lutz H (1991). Vaccination
of cats experimentally infected with feline immunodeficiency virus, using a
recombinant feline leukemia virus vaccine. Journal of the American Veterinary
Medical Association 199(10):1446-52.
Levy JK, Scott HM, Lachtara JL, Crawford PC. (2006). Seroprevalence of feline leukemia
virus and feline immunodeficiency virus infection among cats in North America and
risk factors for seropositivity. J Am Vet Med Assoc 228(3):371-6.
Lewis MG, Mathes LE, Olsen RG (1981). Protection against feline leukemia by vaccination
with a subunit vaccine. Infection & Immunity 34(3):888-94.
Louwerens M, London CA, Pedersen NC, Lyons LA (2005). Feline lymphoma in the postfeline
leukemia virus era. J Vet Intern Med 19(3):329-35.
Lutz H, Pedersen N, Higgins J, Hubscher U, Troy FA, Theilen GH. (1980a). Humoral
immune reactivity to feline leukemia virus and associated antigens in cats naturally
infected with feline leukemia virus. Cancer Research 40(10):3642-51.
Lutz H, Pedersen NC, Harris CW, Higgins J, G.H. T. (1980b). Detection of feline leukemia
virus infection. Feline Pract 10 , 13-23.
Lutz H, Pedersen NC, Higgins J, Harris HW, Theilen GH. (1980c). Quantitation of p27 in the
serum of cats during natural infection with feline leukemia virus. In: Feline Leukemia
Virus, Hardy WD, Essex M, McClelland A, eds; Development in Cancer Res 4 , 497-
505, Elsevier/North Holland.
Lutz H, Pedersen NC, Durbin R, Theilen GH. (1983a). Monoclonal antibodies to three
epitopic regions of feline leukemia virus p27 and their use in enzyme-linked
immunosorbent assay of p27. Journal of Immunological Methods 56(2):209-20.
Lutz H, Pedersen NC, Theilen GH. (1983b). Course of feline leukemia virus infection and its
detection by enzyme-linked immunosorbent assay and monoclonal antibodies.
American Journal of Veterinary Research 44(11):2054-9.
Lutz H, Lehmann R, Winkler G, Kottwitz B, Dittmer A, Wolfensberger C, Arnold P (1990).
Feline immunodeficiency virus in Switzerland: clinical aspects and epidemiology in
comparison with feline leukemia virus and coronaviruses. Schweiz Arch Tierheilkd
132(5):217-25.
Lutz H, Castelli I, Ehrensperger F, Pospischil A, Rosskopf M, Siegl G, Grob M, Martinod S
(1995). Panleukopenia-like syndrome of FeLV caused by co-infection with FeLV and
feline panleukopenia virus. Veterinary Immunology & Immunopathology 46(1-2):21-
33.
McCaw DL, Boon GD, Jergens AE, Kern MR, Bowles MH, Johnson JC. (2001).
Immunomodulation therapy for feline leukemia virus infection. J Am Anim Hosp
Assoc ;37:356-63.
Moore FM, Emerson WE, Cotter SM, DeLellis RA (1986). Distinctive peripheral lymph node
hyperplasia of young cats, Vet Pathol 23:386,
Ogilvie GK, Sundberg JP, O'Banion MK, Badertscher RR 2nd, Wheaton LG, Reichmann ME.
(1988). Clinical and immunologic aspects of FeLV-induced immunosuppression. Vet
Microbiol Jul;17(3):287-96.
Orosz CG, Zinn NE, Olsen RG, Mathes LE (1985a). Retrovirus-mediated
immunosuppression. I. FeLV-UV and specific FeLV proteins alter T lymphocyte
behavior by inducing hyporesponsiveness to lymphokines. Journal of Immunology
134(5):3396-403.
Orosz CG, Zinn NE, Olsen RG, Mathes LE. (1985b). Retrovirus-mediated
immunosuppression. II. FeLV-UV alters in vitro murine T lymphocyte behavior by
reversibly impairing lymphokine secretion. Journal of Immunology 135(1):583-90.
Pacitti AM, Jarrett O, Hay D. (1986). Transmission of feline leukaemia virus in the milk of a
non-viraemic cat. Veterinary Record 118(14):381-4.
Paoletti E. (1996). Applications of pox virus vectors to vaccination: an update. PNAS
93(21):11349-53.
Pedersen NC, Theilen GH, Werner LL. (1979). Safety and efficacy studies of live- and killedfeline
leukemia virus vaccines. American Journal of Veterinary Research 40(8):1120-
6.
Perryman LE, Hoover EA, Yohn DS. (1972). Immunologic reactivity of the cat:
immunosuppression in experimental feline leukemia. J Natl Cancer Inst 49(5):1357-
65.
Pinches MD, Diesel G, Helps CR, Tasker S, Egan K, Gruffydd-Jones TJ (2007). An update
on FIV and FeLV test performance using a Bayesian statistical approach. Vet Clin
Pathol.;36(2):141-7.
Quigley JG, Burns CC, Anderson MM, Lynch ED, Sabo KM, Overbaugh J, Abkowitz JL.
(2000). Cloning of the cellular receptor for feline leukemia virus subgroup C (FeLVC),
a retrovirus that induces red cell aplasia. Blood 95(3):1093-9.
Reinacher M. (1987). Feline leukemia virus-associated enteritis--a condition with features of
feline panleukopenia. Vet Pathol 24(1):1-4.
Reinacher M, Theilen G. (1987). Frequency and significance of feline leukemia virus
infection in necropsied cats. Am J Vet Res 48(6):939-45.
Reinacher M (1989). Diseases associated with spontaneous feline leukaemia virus (FeLV)
infection in cats. Vet Immunol immunopathol 21:85,
Robinson A, DeCann K, Aitken E, Gruffydd-Jones TJ, Sparkes AH, Werret G, Harbour DA
(1998). Comparison of a rapid immunomigration test and ELISA for FIV antibody and
FeLV antigen testing in cats. Vet Rec.;142(18):491-2.
Rojko JL, Hoover EA, Mathes LE, Olsen RG, Schaller JP. (1979). Pathogenesis of
experimental feline leukemia virus infection. Journal of the National Cancer Institute
63(3):759-68.
Rojko JL, Hoover EA, Quackenbush SL, Olsen RG. (1982). Reactivation of latent feline
leukaemia virus infection. Nature 22;298(5872):385-8.
Russell PH, Jarrett O. (1978). The specificity of neutralizing antibodies to feline leukaemia
viruses. Int J Cancer 21(6):768-78.
Sarma PS, Gilden RV, Huebner RJ. (1971). A complement-fixation test for detection of viral
antigens and infective virus of feline leukemia and sarcoma. J Am Vet Med Assoc
158(6):Suppl 2:1055+.
Sarma PS, Tseng J, Lee YK, Gilden RV. (1973). Virus similar to RD114 virus in cat cells.
Nat New Biol 244(132):56-9.
Scarlett JM, Pollock RV. (1991). Year two of follow-up evaluation of a randomized, blind
field trial of a commercial feline leukemia virus vaccine. Journal of the American
Veterinary Medical Association 199(10):1431-2.
Scott DW, Schultz RD, Post JE, Bolton GR, Baldwin CA (1973). Autoimmune haemolytic
anemia in the cat. J Am Anim Hosp Assoc 9(6):530-547
Soe LH, Devi BG, Mullins JI, Roy-Burman P. (1983). Molecular cloning and characterization
of endogenous feline leukemia virus sequences from a cat genomic library. Journal of
Virology 46(3):829-40.
Sparkes AH (2003). Feline leukaemia virus and vaccination. J Feline Med Surg;5(2):97-100
Tandon R, Cattori V, Gomes-Keller MA, Meli ML, Golder MC, Lutz H, Hofmann-Lehmann
R. (2005). Quantitation of feline leukaemia virus viral and proviral loads by TaqMan
real-time polymerase chain reaction. J Virol Methods 130(1-2):124-32.
Tandon R, Cattori V, Willi B, Meli ML, Gomes-Keller MA, Lutz H, Hofmann-Lehmann R.
(2007). Copy number polymorphism of endogenous feline leukemia virus-like
sequences. Mol Cell Probes 21(4):257-66.
Tartaglia J, Jarrett O, Neil JC, Desmettre P, Paoletti E. (1993). Protection of cats against
feline leukemia virus by vaccination with a canarypox virus recombinant, ALVACFL.
Journal of Virology 67(4):2370-5.
Tenorio AP, Franti CE, Madewell BR, Perdersen NC (1991). Chronic oral infections of cats
and their relationship to persistent oral carriage of feline calici-, immunodeficiency, or
leukaemia viruses. Vet Immunol Immunopathol 29(1-2):1-14.
Temin HM, Mizutani S. (1970). RNA-dependent DNA polymerase in virions of Rous
sarcoma virus. Nature 226(5252):1211-3.
Vail D.M., Thamm D. (2005). Hematopoietic tumors. In: Textbook of Veterinary Internal
Medicine, Ettinger S.J., Feldman E.C. eds., 732-747, Elsevier Saunders, Missour
Weijer K, UytdeHaag FG, Jarrett O, Lutz H, Osterhaus AD. (1986). Post-exposure treatment
with monoclonal antibodies in a retrovirus system: failure to protect cats against feline
leukemia virus infection with virus neutralizing monoclonal antibodies. International
Journal of Cancer 38(1):81-7.